Pharmaceutical Preparations
"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
| Descriptor ID |
D004364
|
| MeSH Number(s) |
D26
|
| Concept/Terms |
Pharmaceutical Preparations- Pharmaceutical Preparations
- Pharmaceutic Preparations
- Preparations, Pharmaceutic
- Preparations, Pharmaceutical
- Drugs
- Pharmaceutical Products
- Products, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".
Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".
This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 2 | 3 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 3 | 1 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 4 | 1 | 5 |
| 2020 | 6 | 1 | 7 |
| 2021 | 13 | 0 | 13 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.
-
Special designations and the US Food and Drug Administration's "dual mandate". J Natl Cancer Inst. 2024 Feb 08; 116(2):177-179.
-
Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval. J Ocul Pharmacol Ther. 2023 10; 39(8):572-582.
-
Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma. ACS Nano. 2023 12 12; 17(23):23374-23390.
-
Crystal and Particle Engineering - An Indispensable Tool for Developing and Manufacturing Quality Pharmaceutical Products. Pharm Res. 2022 12; 39(12):3041-3045.
-
Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021. JAMA Netw Open. 2022 11 01; 5(11):e2242869.
-
Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis. Am J Rhinol Allergy. 2022 Nov; 36(6):733-740.
-
The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings. Int J Environ Res Public Health. 2022 02 16; 19(4).
-
Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension. Nat Commun. 2022 01 10; 13(1):46.
-
Digital Additional Risk Minimization Measures: An Exploratory Study Using Qualitative Feedback from Healthcare Professionals and Patients Across Six Countries. Pharmaceut Med. 2022 02; 36(1):21-32.
-
Development of an LC-MS/MS Method for Measurement of Irinotecan and Its Major Metabolites in Plasma: Technical Considerations. Lab Med. 2022 Jan 06; 53(1):47-52.